Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 1;11(2):27.
doi: 10.1167/tvst.11.2.27.

Validation of the Modified Schein Dry Eye Symptom Questionnaire and Comparison With the Ocular Surface Disease Index

Affiliations

Validation of the Modified Schein Dry Eye Symptom Questionnaire and Comparison With the Ocular Surface Disease Index

Jerry R Paugh et al. Transl Vis Sci Technol. .

Abstract

Purpose: This study evaluated the validity and diagnostic efficacy of a modified Schein dry eye questionnaire and compared it to the Ocular Surface Disease Index (OSDI).

Methods: The original Schein survey was modified to allow numerical scoring on a 0 to 24 scale and evaluated in prospective studies in normal and dry eye subjects. Receiver operating characteristic (ROC) analysis for test efficacy in aqueous deficient dry eye (ADDE) and evaporative dry eye (EDE) related to meibomian gland dysfunction was determined.

Results: Dry eye subtype, age and gender were statistically significant in explaining variation in modified Schein scores (n = 377; general linear model; all P values < 0.006) whereas for Ocular Surface Disease Index (OSDI) only age and gender were significant, but not dry eye subtype. The modified Schein ROC curve had an area under the curve (AUC) of 0.693 (95% confidence interval [CI], 0.635-0.753), with cutpoint of 7.5 (sensitivity of 0.75, specificity of 0.55). Similarly, the OSDI had an AUC of 0.685 (95% CI, 0.610-0.760), at a cutpoint of 10.4 (sensitivity of 0.75, specificity of 0.55). Modified Schein and OSDI correlated well (Pearson r = 0.81; P < 0.001). Symptom change for the modified Schein with artificial tear treatment was significant in EDE subjects (Dunnet's tests, P value < 0.001).

Conclusions: The modified Schein questionnaire is rapid to administer and score and compares well with the OSDI for test efficacy. Moreover, it differentiates normals from ADDE and EDE subtypes and is responsive to dry eye treatment. These attributes make the modified Schein survey an attractive dry eye symptom characterization instrument.

Translational relevance: The modified Schein symptom survey, validated against clinical diagnosis and an existing survey, provides a new, efficacious diagnostic and treatment monitoring instrument in dry eye disease.

PubMed Disclaimer

Conflict of interest statement

Disclosure: J.R. Paugh, None; E. Chen, None; J. Kwan, Coopervision Inc. (E); T. Nguyen, None; A. Sasai, None; M. Thomas De Jesus, LensGen (E); A.L. Nguyen, None; M.T. Christensen, None; D. Meadows, None

Figures

Figure 1.
Figure 1.
The Modified Schein Questionnaire.
Figure 2.
Figure 2.
ROC curves for normals (non-dry eye subjects) versus combined ADDE and EDE subtypes.
Figure 3.
Figure 3.
Bland Altman plot of modified Schein repeatability. The mean difference is very small, demonstrating little bias of repeated scores.
Figure 4.
Figure 4.
The Person–Item map demonstrates a broad spread for the six symptom items, frequent reports of dryness, and infrequent reports of eyes stuck shut.
Figure 5.
Figure 5.
Modified Schein and OSDI correlation for all subjects, normal, and both dry eye subtypes.

References

    1. Smith JA, Albietz J, Begley C, et al.. The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Workshop. Ocul Surf. 2007; 5: 27–41. - PubMed
    1. Wolffsohn JS, Arita R, Chalmers R, et al.. TFOS DEWS II Diagnostic Methodology report. Ocul Surf. 2017; 15: 539–574. - PubMed
    1. Schein OD, Tielsch JM, Munoz MS, Bandeen-Roche K, West S.. Relation between signs and symptoms of dry eye in the elderly. Ophthalmology. 1997; 104: 1395–1401. - PubMed
    1. Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks GN.. The International Workshop on Meibomian Gland Dysfunction: report of the Definition and Classification Subcommittee. Invest Ophthalmol Vis Sci. 2011; 52: 1930–1937. - PMC - PubMed
    1. Sung J, Wang MTM, Lee SH, et al.. Randomized double-masked trial of eyelid cleansing treatments for blepharitis. Ocul Surf. 2018; 16: 77–83. - PubMed

Publication types